Latest Investments News

Altech Batteries has won conditional approval for a €46.11 million German government grant supporting its CERENERGY® Sodium-Chloride Solid-State battery project, while shifting its Silumina AnodesTM R&D operations to Germany to enhance efficiency and cut costs.

Orbital Corporation advances its UAV engine production and hybrid propulsion technology while managing a $0.5 million net cash outflow in Q1 2026, supported by a $43 million business pipeline and new international contracts.

Conrad Asia Energy has taken a decisive step from exploration to production with the Final Investment Decision on its Mako Gas Project, booking reserves for the first time and progressing a major farm-down transaction.

Starpharma has confirmed FDA alignment for its DEP® HER2 first-in-human phase 1 trial, with preparations underway for a mid-2026 start. The biotech also progressed strategic partnerships, published promising data with Genentech, and reported a $14.1 million cash balance alongside rising Viraleze™ sales.

Green Technology Metals (ASX: GT1) sharpens focus on its Seymour Lithium Project amid a lithium price rebound, key permitting progress, and extended C$100 million financing interest from Export Development Canada.

Neurotech International has opened its first Phase 3 clinical site for NTI164 targeting Autism Spectrum Disorder, reported positive 90-day toxicology results, and launched a new Rett syndrome research collaboration.

Anax Metals’ updated DFS for Whim Creek reveals a 113% surge in free cash flow to A$723 million, underpinned by a decade-long mine life and rapid payback. The company’s $10 million capital raise strengthens its balance sheet following full repayment of a $3.5 million loan.

Carma Limited surged past prior year sales with 1,344 units sold, boosted by rapid network expansion and improved reconditioning efficiency, while maintaining a solid cash position.

CZR Resources has unveiled strong assay results from its Croydon Gold Project, confirming a significant gold system open in all directions. The company advances exploration at Edamurta and Yarrie, supported by a robust cash position.

Minerals 260 has secured a $59.1 million fixed-price contract with ATCO to build a 400-person accommodation village at its Bullabulling Gold Project, marking a key step towards construction readiness.

Mayne Pharma’s third quarter results show modest revenue growth but a sharp improvement in cash flow and earnings, powered by the strong launch of DistributeRx and robust Women’s Health sales.

Dundas Minerals has secured $2.5 million to fund extensive drilling across its Western Australian gold portfolio, exercised its option to acquire the Rockland mining lease, and expanded the Romano project with a new exploration licence application near Gruyere.